– USA, PA – Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP), a biopharmaceutical company developing innovative cell therapy platforms for cancer, today announced the appointments to the board of directors following the completion of the business combination between Coeptis Therapeutics, Inc.…
– USA, MD – Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy, today announced the appointment of Dr.…
– USA, CA – Sagimet Biosciences, a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic pathways, today announced the appointment of David Happel as CEO, replacing Dr.…
– CANADA, Montreal – Inversago Pharma Inc., a clinical-stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists, today announced the appointments of Ed Mathers and Dr.…
– USA, TX – AustinPx, Pharmaceutics and Manufacturing, a contract development and manufacturing organization, today announced the appointments of Derek Hennecke and Marshall Crew to its Board as independent directors, bringing additional experienced CDMO leadership to drive growth in the complex formulation and manufacturing market.…